Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Optomed Oyj
  6. Summary
    OPTOMED   FI4000410881

OPTOMED OYJ

(OPTOMED)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Helsinki
01/17/2022 01/18/2022 01/19/2022 01/20/2022 01/21/2022 Date
9.54(c) 9.52(c) 9.34(c) 9.46(c) 8.9 Last
13 240 10 432 21 215 14 854 24 966 Volume
+0.85% -0.21% -1.89% +1.28% -5.92% Change
More quotes
Estimated financial data (e)
Sales 2021 15,4 M 17,4 M 17,4 M
Net income 2021 -3,63 M -4,12 M -4,12 M
Net Debt 2021 0,33 M 0,37 M 0,37 M
P/E ratio 2021 -35,0x
Yield 2021 -
Sales 2022 18,1 M 20,5 M 20,5 M
Net income 2022 -4,35 M -4,93 M -4,93 M
Net Debt 2022 4,95 M 5,61 M 5,61 M
P/E ratio 2022 -29,6x
Yield 2022 -
Capitalization 128 M 145 M 145 M
EV / Sales 2021 8,36x
EV / Sales 2022 7,35x
Nbr of Employees 118
Free-Float -
More Financials
Company
Optomed Plc is a Finland-based company engaged in the health care technology industry. The Company provides handheld fundus cameras and software solutions with integrated artificial intelligence for screening of blinding eye diseases. Its customers include international health care organizations, hospitals, and global medical technology companies and distributors. 
More about the company
Ratings of Optomed Oyj
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about OPTOMED OYJ
01/13Optomed Announces Promising Research Results with Aurora Handheld Fundus Camera
CI
01/13OPTOMED OYJ : Promising research results with Optomed's handheld fundus camera
PU
2021OPTOMED OYJ : webinar on December 9, 2021
PU
2021Change in Optomed's holding of treasury
AQ
2021Optomed Oyj Provides Earnings Guidance for the Year 2021
CI
2021OPTOMED PLC : Interim report, January - September 2021
AQ
2021Optomed Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended Septem..
CI
2021Optomed's Jan–Sept 2021 interim report to be published on 4 November 2021
PU
2021Optomed's January–September 2021 interim report to be published on 4 November 202..
PU
2021OPTOMED OYJ(HLSE : OPTOMED) added to S&P Global BMI Index
CI
2021OPTOMED OYJ : Composition of Optomed's Nomination Board
PU
2021OPTOMED OYJ : Composition of Optomed's Nomination Board
AQ
2021Optomed Oyj Announces Composition of Its Nomination Board
CI
2021OPTOMED OYJ : Keppler Medtech Seminar
PU
2021OPTOMED PLC : - Managers' transactions - Salonen
AQ
More news
News in other languages on OPTOMED OYJ
01/13Optomed annonce des résultats de recherche prometteurs avec la caméra Fundus portable A..
2021Optomed Oyj fournit des prévisions de bénéfices pour l'année 2021
2021Optomed Oyj fournit des prévisions de revenus pour l'année 2021
2021Optomed Oyj revoit à la hausse ses prévisions de recettes pour l'année 2021
2021Optomed fournit des prévisions de revenus pour l'année complète de l'exercice 2021
More news
Chart OPTOMED OYJ
Duration : Period :
Optomed Oyj Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPTOMED OYJ
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 9,46 €
Average target price 11,90 €
Spread / Average Target 25,8%
EPS Revisions
Managers and Directors
Seppo Henrik Kopsala Chief Executive Officer
Lars Goran Lindqvist Chief Financial Officer
Petri Paavali Salonen Chairman
Petri Huhtinen Clinical Director
Seppo Olavi Mńkinen Independent Director
Sector and Competitors
1st jan.Capi. (M$)
OPTOMED OYJ-3.47%145
THERMO FISHER SCIENTIFIC-11.85%231 763
DANAHER CORPORATION-14.00%202 197
INTUITIVE SURGICAL, INC.-18.53%104 574
SIEMENS HEALTHINEERS AG-6.05%78 653
EDWARDS LIFESCIENCES CORPORATION-10.80%72 148